A phase II study of ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory aggressive B-cell lymphoma prior to autologous stem cell transplantation (ASCT) Meeting Abstract
| Authors: | Matasar, M. J.; Czuczman, M. S.; Rodriguez, M. A.; Fennessy, M.; Shea, T. C.; Spitzer, G.; Lossos, I. S.; Kharfan-Dabaja, M. A.; Joyce, R.; Fayad, L.; Liao, Q. M.; Edvardsen, K.; Lisby, S.; Moskowitz, C. H. |
| Abstract Title: | A phase II study of ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory aggressive B-cell lymphoma prior to autologous stem cell transplantation (ASCT) |
| Meeting Title: | 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis |
| Journal Title: | Blood |
| Volume: | 118 |
| Issue: | 21 |
| Meeting Dates: | 2011 Dec 10-13 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2011-11-01 |
| Start Page: | 437 |
| End Page: | 438 |
| Language: | English |
| ACCESSION: | WOS:000299597101228 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V118.21.957.957 |
| Notes: | --- - Meeting Abstract: 957 - 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis - DEC 10-13, 2011 - San Diego, CA - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work